NOTV Inotiv Inc
Price (delayed)
$2.87
Market cap
$97.2M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.61
Enterprise value
$506.27M
Bioanalytical Systems, Inc., operating as Inotiv, is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development companies and
Highlights
NOTV's quick ratio is up by 24% since the previous quarter but it is down by 2.9% year-on-year
NOTV's gross profit is down by 46% YoY and by 8% QoQ
NOTV's gross margin is down by 34% year-on-year and by 4.8% since the previous quarter
Key stats
What are the main financial stats of NOTV
Market
Valuations
Earnings
Shares outstanding
33.87M
Market cap
$97.2M
Enterprise value
$506.27M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.44
Price to sales (P/S)
0.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.07
Revenue
$475.11M
Gross profit
$102.74M
Operating income
-$92.54M
Net income
-$120.69M
EBIT
-$91.89M
EBITDA
-$34.84M
Free cash flow
-$22.01M
Per share
Balance sheet
Liquidity
EPS
-$4.61
EPS diluted
-$4.61
Free cash flow per share
-$0.81
Book value per share
$6.53
Revenue per share
$17.49
TBVPS
$15.24
Total assets
$772.91M
Total liabilities
$603.08M
Debt
$447.11M
Equity
$169.83M
Working capital
$62.29M
Debt to equity
2.63
Current ratio
1.57
Quick ratio
0.99
Net debt/EBITDA
-11.74
Margins
Efficiency
Dividend
EBITDA margin
-7.3%
Gross margin
21.6%
Net margin
-25.4%
Operating margin
-19.5%
Return on assets
-15.4%
Return on equity
-66.2%
Return on invested capital
-17.6%
Return on capital employed
-13.8%
Return on sales
-19.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NOTV stock price
How has the Inotiv stock price performed over time
Intraday
19.09%
1 week
26.43%
1 month
-6.82%
1 year
-69.76%
YTD
-30.68%
QTD
29.86%
Financial performance
How have Inotiv's revenue and profit performed over time
Revenue
$475.11M
Gross profit
$102.74M
Operating income
-$92.54M
Net income
-$120.69M
Gross margin
21.6%
Net margin
-25.4%
NOTV's gross profit is down by 46% YoY and by 8% QoQ
NOTV's gross margin is down by 34% year-on-year and by 4.8% since the previous quarter
Inotiv's revenue has decreased by 19% YoY and by 3.2% QoQ
The net margin has contracted by 15% from the previous quarter
Growth
What is Inotiv's growth rate over time
Valuation
What is Inotiv stock price valuation
P/E
N/A
P/B
0.44
P/S
0.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.07
Inotiv's EPS has decreased by 10% from the previous quarter
The P/B is 91% lower than the 5-year quarterly average of 4.2 and 38% lower than the last 4 quarters average of 0.6
The equity has declined by 33% year-on-year
The price to sales (P/S) is 91% less than the 5-year quarterly average of 1.5 and 30% less than the last 4 quarters average of 0.2
Inotiv's revenue has decreased by 19% YoY and by 3.2% QoQ
Efficiency
How efficient is Inotiv business performance
Inotiv's return on equity has decreased by 24% QoQ
The ROA fell by 14% QoQ
Inotiv's ROS has decreased by 14% from the previous quarter
The ROIC is down by 11% QoQ
Dividends
What is NOTV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NOTV.
Financial health
How did Inotiv financials performed over time
The total assets is 28% greater than the total liabilities
NOTV's quick ratio is up by 24% since the previous quarter but it is down by 2.9% year-on-year
Inotiv's current ratio has increased by 15% QoQ but it has decreased by 10% YoY
The debt is 163% more than the equity
The company's debt to equity has surged by 56% YoY
The equity has declined by 33% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.